E. Greselin
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Inflammatory mediators and NSAID effects 4
- Drug-Induced Hepatotoxicity and Protection 4
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- D. Dvornik (11 shared papers)Mitchell N. Cayen (10 shared papers)Eckhardt S. Ferdinandi (6 shared papers)N. Simard-Duquesne (2 shared papers)J.-E. Dubuc (5 shared papers)M. Kraml (4 shared papers)William T. Robinson (1 shared paper)Claude Viau (2 shared papers)
- Journals
- Canadian Journal of Physiology and Pharmacology (3 papers)Atherosclerosis (3 papers)Experimental Biology and Medicine (2 papers)Toxicology and Applied Pharmacology (2 papers)Xenobiotica (2 papers)
- Partner nations
- CanadaUnited States
In The Last Decade
E. Greselin
28 papers receiving 323 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 77
- Biochemistry 42
- Cell Biology 91
- Clinical Biochemistry 34
- Pharmacology 72
Countries citing papers authored by E. Greselin
This map shows the geographic impact of E. Greselin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Greselin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Greselin more than expected).
Fields of papers citing papers by E. Greselin
This network shows the impact of papers produced by E. Greselin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Greselin. The network helps show where E. Greselin may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Greselin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 49 | |
| 2 | 1985 | 46 | |
| 3 | 1977 | 44 | |
| 4 | 1985 | 39 | |
| 5 | 1979 | 39 | |
| 6 | 1973 | 33 | |
| 7 | 1985 | 14 | |
| 8 | 1982 | 14 | |
| 9 | 1991 | 13 | |
| 10 | 1990 | 12 | |
| 11 | An inhibitor of cholesterol biosynthesis and the alveolar macrophages. | 1966 | 10 |
| 12 | 1964 | 9 | |
| 13 | 1967 | 8 | |
| 14 | Lack of vitamin E cytoprotective effects on indomethacin-induced gastric lesions. | 1991 | 7 |
| 15 | 1967 | 7 | |
| 16 | 1983 | 6 | |
| 17 | 1982 | 5 | |
| 18 | 1992 | 4 | |
| 19 | Detection of Otitis Media in the Rat. | 1961 | 4 |
| 20 | 1988 | 3 |
About E. Greselin
E. Greselin is a scholar working on Molecular Biology, Pharmacology, Epidemiology, Surgery and Biochemistry, having authored 29 papers that have together received 383 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (5 papers), Inflammatory mediators and NSAID effects (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Vitamin C and Antioxidants Research (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Aldose Reductase and Taurine (3 papers). The work is most often cited by research in Pharmacology (77 citations), Biochemistry (42 citations), Cell Biology (91 citations), Clinical Biochemistry (34 citations) and Pharmacology (72 citations). E. Greselin has collaborated with scholars based in Canada and United States. Frequent co-authors include D. Dvornik, Mitchell N. Cayen, Eckhardt S. Ferdinandi, N. Simard-Duquesne, J.-E. Dubuc, M. Kraml, William T. Robinson, Claude Viau, Peter Hill and C. I. Chappel. Their work appears in journals such as Canadian Journal of Physiology and Pharmacology, Atherosclerosis, Experimental Biology and Medicine, Toxicology and Applied Pharmacology and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.